The role of diet in hyperuricemia and gout.
Journal
Current opinion in rheumatology
ISSN: 1531-6963
Titre abrégé: Curr Opin Rheumatol
Pays: United States
ID NLM: 9000851
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
6
1
2021
medline:
16
10
2021
entrez:
5
1
2021
Statut:
ppublish
Résumé
Although gout's cardinal feature is inflammatory arthritis, it is closely associated with insulin resistance and considered a manifestation of the metabolic syndrome. As such, both gout and hyperuricemia are often associated with major cardiometabolic and renal comorbidities that drive the persistently elevated premature mortality rates among gout patients. To that end, conventional low-purine (i.e., low-protein) dietary advice given to many patients with gout warrant reconsideration. Recent research suggests that several healthy diets, such as the Mediterranean or Dietary Approaches to Stop Hypertension (DASH) diets, in combination with weight loss for those who are overweight or obese, can drastically improve cardiometabolic risk factors and outcomes. By treating gout as a part of the metabolic syndrome and shifting our dietary recommendations to these healthy dietary patterns, the beneficial effects on gout endpoints should naturally follow for the majority of typical gout cases, mediated through changes in insulin resistance. Dietary recommendations for the management of hyperuricemia and gout should be approached holistically, taking into consideration its associated cardiometabolic comorbidities. Several healthy dietary patterns, many with similar themes, can be tailored to suit comorbidity profiles and personal preferences.
Identifiants
pubmed: 33399399
doi: 10.1097/BOR.0000000000000779
pii: 00002281-202103000-00006
pmc: PMC7886025
mid: NIHMS1665790
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
135-144Subventions
Organisme : NIAMS NIH HHS
ID : P50 AR060772
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR065944
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR007258
Pays : United States
Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002; 29:1350–1355.
Choi HK, Mount DB, Reginato AM, et al. Pathogenesis of gout. Ann Intern Med 2005; 143:499–516.
Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES. Am J Med 2012; 125:679–687.e1.
Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC. Association of kidney disease with prevalent gout in the United States in 1998–1994 and 2007–2010. Semin Arthritis Rheum 2013; 42:551–561.
Juraschek SP, Kovell LC, Miller ER, Gelber AC. Dose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout. PLoS One 2013; 8:e56546.
Dessein PH, Shipton EA, Stanwix AE, et al. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000; 59:539–543.
Ter Maaten JC, Voorburg A, Heine RJ, et al. Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 1997; 92:51–58.
Muscelli E, Natali A, Bianchi S, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996; 9:746–752.
Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266:3008–3011.
Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007; 57:109–115.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356–359.
Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120:442–447.
Choi HK, De Vera MA, Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford) 2008; 47:1567–1570.
Baker JF, Schumacher HR, Krishnan E. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology 2007; 58:450–457.
Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 1988; 41:237–242.
Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006; 54:2688–2696.
Krishnan E, Svendsen K, Neaton JD, et al. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008; 168:1104–1110.
Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116:894–900.
Fisher MC, Rai SK, Lu N, et al. The unclosing premature mortality gap in gout: a general population-based study. Ann Rheum Dis 2017; 76:1289–1294.
Zhang Y, Lu N, Peloquin C, et al. Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 2017; 76:408–413.
Safiri S, Kolahi AA, Cross M, et al. Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990–2017: a systematic analysis of the global burden of disease study. Arthritis Rheumatol 2020; 72:1916–1927.
Xia Y, Wu Q, Wang H, et al. Global, regional and national burden of gout, 1990–2017: a systematic analysis of the Global Burden of Disease Study. Rheumatology (Oxford) 2020; 59:1529–1538.
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey. Arthritis Rheum 2011; 63:3136–3141.
Young LR, Nestle M. The contribution of expanding portion sizes to the US obesity epidemic. Am J Public Health 2002; 92:246–249.
Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 2017; 390:2627–2642.
Wang YC, McPherson K, Marsh T, et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011; 378:815–825.
Hu F. Hu F. Genetic predictors of obesity. Oxford University Press, Obesity epidemiology. New York City: 2008.
Choi HK, McCormick N, Lu N, et al. Population impact attributable to modifiable risk factors for hyperuricemia. Arthritis Rheumatol 2020; 72:157–165.
Du Y, Liu B, Sun Y, et al. Trends in adherence to the physical activity guidelines for Americans for Aerobic Activity and time spent on sedentary behavior among US adults, 2007 to 2016. JAMA Netw Open 2019; 2:e197597.
Yang L, Cao C, Kantor ED, et al. Trends in sedentary behavior among the US population. JAMA 2019; 321:1587–1597.
Yokose C, McCormick N, Rai SK, et al. Effects of low-fat, Mediterranean, or low-carbohydrate weight loss diets on serum urate and cardiometabolic risk factors: a secondary analysis of the Dietary Intervention Randomized Controlled Trial (DIRECT). Diabetes Care 2020; 43:2812–2820.
Emmerson B. Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 1998; 57:509–510.
Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:2960–2984.
Jang WC, Nam YH, Park SM, et al. T6092C polymorphism of SLC22A12 gene is associated with serum uric acid concentrations in Korean male subjects. Clin Chim Acta 2008; 398:140–144.
Mellen PB, Gao SK, Vitolins MZ, Goff DC Jr. Deteriorating dietary habits among adults with hypertension: DASH dietary accordance, NHANES 1988–1994 and 1999–2004. Arch Intern Med 2008; 168:308–314.
U.S. Department of Health and Human Services, U.S. Department of Agriculture. 2015–2020 dietary guidelines for Americans, 8th ed.
Hu FB. The Mediterranean diet and mortality: olive oil and beyond. N Engl J Med 2003; 348:2595–2596.
Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med 2018; 378:e34.
Fung TT, Rexrode KM, Mantzoros CS, et al. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009; 119:1093–1100.
Filippatos TD, Panagiotakos DB, Georgousopoulou EN, et al. Mediterranean diet and 10-year (2002–2012) incidence of diabetes and cardiovascular disease in participants with prediabetes: the ATTICA study. Rev Diabet Stud 2016; 13:226–235.
Buckland G, Gonzalez CA, Agudo A, et al. Adherence to the Mediterranean diet and risk of coronary heart disease in the Spanish EPIC Cohort Study. Am J Epidemiol 2009; 170:1518–1529.
Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348:2599–2608.
Sotos-Prieto M, Bhupathiraju SN, Mattei J, et al. Changes in diet quality scores and risk of cardiovascular disease among US men and women. Circulation 2015; 132:2212–2219.
Sotos-Prieto M, Bhupathiraju SN, Mattei J, et al. Association of changes in diet quality with total and cause-specific mortality. N Engl J Med 2017; 377:143–153.
de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343:1454–1459.
Salas-Salvado J, Bullo M, Babio N, et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011; 34:14–19.
de Koning L, Chiuve SE, Fung TT, et al. Diet-quality scores and the risk of type 2 diabetes in men. Diabetes Care 2011; 34:1150–1156.
Shai I, Schwarzfuchs D, Henkin Y, et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008; 359:229–241.
Guasch-Ferre M, Bullo M, Babio N, et al. Mediterranean diet and risk of hyperuricemia in elderly participants at high cardiovascular risk. J Gerontol A Biol Sci Med Sci 2013; 68:1263–1270.
Keller S, Lu RS, Zhang L, et al. The Dietary Approaches to Stop Hypertension (DASH) and Mediterranean diets and risk of gout in women: 28-year follow-up of a prospective cohort [abstract]. Arthritis Rheumatol 2017; 69: (Suppl. 10):
Sacks FM, Campos H. Dietary therapy in hypertension. N Engl J Med 2010; 362:2102–2112.
Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117–1124.
Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3–10.
Appel LJ, Sacks FM, Carey VJ, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294:2455–2464.
Belanger MW, Mukamal K, Miller E, et al. The effects of dietary macronutrients on serum urate: a secondary analysis of the OmniHeart trial [abstract]. Arthritis Rheumatol 2020; 72: (Suppl. 10): https://acrabstracts.org/abstract/the-effects-of-dietary-macronutrients-on-serum-urate-a-secondary-analysis-of-the-omniheart-trial/https://acrabstracts.org/abstract/the-effects-of-dietary-macronutrients-on-serum-urate-a-secondary-analysis-of-the-omniheart-trial/ (accessed November 18, 2020).
Djousse L, Ho YL, Nguyen XT, et al. DASH score and subsequent risk of coronary artery disease: the findings from Million Veteran Program. J Am Heart Assoc 2018; 7:e008089doi: 10.1161/JAHA.117.008089.
doi: 10.1161/JAHA.117.008089
Fung TT, Chiuve SE, McCullough ML, et al. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 2008; 168:713–720.
Liese AD, Nichols M, Sun X, et al. Adherence to the DASH Diet is inversely associated with incidence of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2009; 32:1434–1436.
Mokhtari Z, Sharafkhah M, Poustchi H, et al. Adherence to the dietary approaches to stop hypertension (DASH) diet and risk of total and cause-specific mortality: results from the Golestan Cohort Study. Int J Epidemiol 2019; 48:1824–1838.
Parikh A, Lipsitz SR, Natarajan S. Association between a DASH-like diet and mortality in adults with hypertension: findings from a population-based follow-up study. Am J Hypertens 2009; 22:409–416.
Park YM, Fung TT, Steck SE, et al. Diet quality and mortality risk in metabolically obese normal-weight adults. Mayo Clin Proc 2016; 91:1372–1383.
Juraschek SP, Gelber AC, Choi HK, et al. Effects of the dietary approaches to stop hypertension (DASH) diet and sodium intake on serum uric acid. Arthritis Rheumatol 2016; 68:3002–3009.
Juraschek SP, White K, Tang O, et al. Effects of a dietary approach to stop hypertension (DASH) diet intervention on serum uric acid in African Americans with hypertension. Arthritis Care Res (Hoboken) 2018; 70:1509–1516.
Gao Y, Cui LF, Sun YY, et al. Adherence to the dietary approaches to stop hypertension (DASH) diet and hyperuricemia: a cross-sectional study. Arthritis Care Res (Hoboken) 2020; doi: 10.1002/acr.24150. [Online ahead of print].
doi: 10.1002/acr.24150.
Rai SK, Fung TT, Lu N, et al. The dietary approaches to stop hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study. BMJ 2017; 357:j1794.
Tran E, Dale HF, Jensen C, Lied GA. Effects of plant-based diets on weight status: a systematic review. Diabetes Metab Syndr Obes 2020; 13:3433–3448.
Satija A, Hu FB. Plant-based diets and cardiovascular health. Trends Cardiovasc Med 2018; 28:437–441.
Chiu TH, Liu CH, Chang CC, et al. Vegetarian diet and risk of gout in two separate prospective cohort studies. Clin Nutr 2020; 39:837–844.
Juraschek SP, Yokose C, McCormick N, et al. Effects of dietary patterns on serum urate: results from the DASH randomized trial. Arthritis Rheum 2020.
Richette P, Clerson P, Perissin L, et al. Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis 2015; 74:142–147.
Bevis M, Blagojevic-Bucknall M, Mallen C, et al. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review. Rheumatology (Oxford) 2018; 57:1358–1363.
Yokose C, Chen-Xu LL, Zhang M, et al. Comorbidity patterns in gout using the US general population: cluster analysis of the National Health and Nutrition Examination Survey. Ann Rheum Dis 2019; 78:A1294.
Zhang Y, Chen C, Choi H, et al. Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis 2012; 71:1448–1453.
Zhang M, Zhang Y, Terkeltaub R, et al. Effect of dietary and supplemental omega-3 polyunsaturated fatty acids on risk of recurrent gout flares. Arthritis Rheumatol 2019; 71:1580–1586.
Neogi T, Chen C, Niu J, et al. Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study. Am J Med 2014; 127:311–318.
Choi HK, Atkinson K, Karlson EW, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363:1277–1281.
Choi HK, Curhan G. Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2004; 51:1023–1029.
Gepner Y, Golan R, Harman-Boehm I, et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial. Ann Intern Med 2015; 163:569–579.
Khanna P, Berrocal V, An L, Khanna D. Development and pilot testing of MyGoutCare: a novel web-based platform to educate patients with gout. J Clin Rheumatol 2019; 26:320–326.
Kang SG, Lee EN. Development and evaluation of a self-management application for patients with gout. Jpn J Nurs Sci 2020; 17:e12285.